Market fragmentation across healthcare supply chain services has created compelling investment opportunities that Waud Capital Partners plans to address through a massive $100 million platform investment. The partnership between founder Reeve Waud and veteran healthcare executive Bill Mixon signals private equity’s growing recognition that post-acute care and specialty distribution offer some of healthcare’s most attractive consolidation plays.
Healthcare supply chain market’s fragmented nature across multiple subsectors—from home distribution to chronic care management—mirrors the conditions that enabled Reeve Waud to build successful platforms in behavioral health, gastroenterology, and other specialty healthcare services over the past three decades.
Market Forces Driving Industry Consolidation
Demographic trends are reshaping healthcare delivery models in ways that favor companies positioned to serve patients across multiple care settings. An aging population increasingly requires specialized medical supplies, durable medical equipment, and chronic disease management services delivered directly to homes rather than traditional institutional settings.
“The healthcare supply chain markets are highly fragmented with significant opportunities for organizations to deliver value-add solutions and address substantial challenges for key stakeholders,” said Mike Lehman, Principal at Waud Capital Partners.
Technology advancement has enabled distributed care models while simultaneously creating operational complexity that specialized service providers can address more efficiently than fragmented local competitors. Reimbursement pressures across Medicare, Medicaid, and commercial payers are forcing healthcare providers to seek cost-effective solutions for equipment management, supply chain optimization, and patient engagement services.
Platform Investment Thesis and Market Positioning
Bill Mixon’s partnership demonstrates Waud Capital Partners’ second dedicated campaign in the medical device and supply chain services market within 24 months, showing accelerated investment activity in this sector. Reeve Waud’s firm has systematically built a portfolio of complementary healthcare supply chain businesses including Mopec Group (pathology equipment and services), PromptCare (home infusion and durable medical equipment), and Provider Network Holdings (specialty medication supply management).
“This is our second dedicated campaign in the medical device and supply chain services market in the last two years and we are thrilled about the prospects of what we can accomplish during our partnership with Bill,” said Kyle Lattner, Partner at Waud Capital.
Targeted subsectors—home distribution, value-add specialty distribution, outsourced provider equipment services, and chronic care management—represent areas where operational expertise and capital resources can create sustainable competitive advantages through economies of scale, technology investment, and clinical specialization.
Reeve Waud’s approach emphasizes building platforms that deliver measurable value to multiple stakeholders across the healthcare ecosystem. Rather than simply consolidating for size, Waud Capital Partners focuses on companies that can demonstrate improved clinical outcomes, operational efficiencies, and cost savings for providers, payers, and patients.
Operational Excellence Blueprint and Value Creation
Bill Mixon’s track record at Advanced Diabetes Supply provides a compelling case study for value creation in healthcare supply chain services. Under his leadership, the company grew from a specialty distributor to a $1 billion revenue enterprise serving nearly 500,000 patients annually through operational improvements including salesforce productivity enhancements, go-to-market refinements, and revenue cycle optimization.
The $1.1 billion acquisition by Cardinal Health in April 2025 validated Mixon’s operational approach and demonstrated market appetite for scaled, efficient healthcare supply chain platforms.
Mixon’s earlier experience at National Seating & Mobility, where he expanded the company to over 200 locations across the United States and Canada, further demonstrates his ability to execute complex growth methodologies across multiple private equity ownership periods. This track record of building and scaling healthcare services businesses aligned perfectly with Reeve Waud’s investment methodology.
Platform Positioning and Future Development
The partnership positions Waud Capital Partners to build what Mixon describes as “an industry-leading business that supports and improves the overall healthcare supply chain.” Focus on clinical value creation for medical professionals, manufacturers, payers, and patients reflects the broader trend toward value-based healthcare delivery models.
“I’m excited to partner with Waud Capital to identify and help build what we hope will be an industry-leading business,” said Mixon. “Waud Capital’s executive partnership approach, dedicated ecosystem resources, and deep investing experience across relevant areas make the firm a highly attractive partner.”
Reeve Waud’s systematic approach to healthcare services consolidation, combined with over $100 million in committed equity capital and Mixon’s proven operational leadership, positions the new platform to capitalize on the ongoing transformation of healthcare supply chain management. The partnership demonstrates calculated assessment that market fragmentation, demographic trends, and technological advancement will continue driving demand for scaled, efficient healthcare supply chain solutions.
Related: Waud Capital Partners Celebrates 30 Years of Partnership